MCM
GMAB icon

Moore Capital Management’s Genmab GMAB Stock Holding History

Moore Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35,400
Closed -$1.25M – 481
2023
Q3 		$1.25M Buy
+35,400
New +$1.35M 0.02% 279

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Moore Capital Management's GMAB Position: Q1 2026 in Review

Moore Capital Management opened a new position in Genmab (GMAB) in Q1 2026: 211,705 shares worth $5.68M. The stake represents 0.12% of the portfolio and ranks #141 among its holdings.

273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Moore Capital Management held 211,705 shares of Genmab worth $5.68M as of Q1 2026.
  • Genmab was a new Moore Capital Management position in Q1 2026.
  • Genmab made up 0.12% of Moore Capital Management's portfolio in Q1 2026, its #141 holding.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.